|
시장보고서
상품코드
2040088
스카이리치 시장 기회 및 전략(-2035년)Skyrizi Global Market Opportunities And Strategies To 2035 |
||||||
The Business Research Company
세계의 스카이리치 시장은 2020년에 15억 9,000만 달러로 평가되었고 2025년까지 연평균 복합 성장률(CAGR) 54.00%를 나타냈습니다.
스카이리치는 염증 및 면역 반응에 관여하는 주요 사이토카인인 인터류킨-23(IL-23)을 선택적으로 저해하는 인간 화 단일클론항체인 리산키즈마브를 포함한 처방전이 필요한 생물학적 제제입니다.본제는 주사에 의해 투여되어 면역 개재성 염증성 질환, 특히 중등도로부터 중증 심상성 건선 치료제로서 승인되고 있습니다.스카이리치 주요 목적은 면역계를 넓게 억제하는 것이 아니라, 특정 면역 경로를 표적으로 하는 것으로, 염증을 경감해, 질환 증상을 컨트롤 하는 것에 있습니다.
스카이리치 시장은 일반적으로 장기적으로 사용되는 스카이리치의 법인(조직, 개인사업자, 파트너십)에 의한 판매로 구성되어 있으며, 투여 간격은 질환의 적응증과 치료 단계에 따라 달라집니다. 이 약은 아달리무맙, 우스테키누맙, 인플릭시맙 등 다른 생물학적 제제나 코르티코스테로이드, 면역억제제 등 비생물학적 전신요법을 보완하거나 대체할 수 있습니다.
환자 접근 프로그램 확대
지난 몇 년 동안 스카이리치 시장은 환자 접근 프로그램 확대에 힘입어 크게 성장했습니다. 의료 시스템이 디지털 의료 인프라와 환자 중심의 접근 프레임워크를 점점 더 많이 도입함에 따라, 만성 질환 관리, 치료 과정 모니터링, 장기 치료 관련 의사 결정 참여에 더 적극적으로 참여하는 환자의 비율이 증가했습니다. 예를 들어, 2025년 9월 HealthIT.gov의 데이터 개요에 따르면 미국 병원은 2021년부터 2024년까지 환자 접근 및 참여 기능을 크게 확장하고 모든 기본 전자 접근 기능(열람, 다운로드, 전송, 메시징)을 도입하고 있습니다. 병원의 비율은 2021년 72%에서 2024년 80%로 증가했습니다. 또한, 임상 기록에 대한 접근이나 앱을 활용한 건강 정보 이용과 같은 새로운 기능도 같은 기간 동안 65%에서 85%로 증가했습니다. 기록 가져오기 및 환자 생성 데이터 제출과 같은 고급 환자 접근 도구는 37%에서 45%를 나타낼 전망입니다. 2024년까지 거의 모든 병원(99%)이 환자의 건강기록을 전자적으로 열람할 수 있도록 하고, 96%는 다운로드를 허용하며, 92%는 의료진과의 안전한 메시징을 지원하게 되었습니다. 따라서, 스카이리치 시장은 이 기간 동안 환자 접근 프로그램 확대에 의해 크게 견인되었습니다.
IL-23 억제제 승인 범위 확대
스카이리치 시장 업체들은 여러 면역 매개 염증성 질환에서 스카이리치의 입지를 강화하기 위해 IL-23 억제제의 적응증 확대에 집중하고 있습니다. 이번 승인 범위 확대로 기존 생물학적 제제에 반응하지 않는 환자들을 포함해 더 크고 다양한 환자층에 대한 접근이 가능해졌습니다. 이번 확대는 스크리치를 다재다능한 질환 조절 치료제로 자리매김함으로써 의사들의 채택을 촉진할 것으로 기대됩니다. 또한, 다중 적응증 승인은 제품 수명주기를 연장하고 경쟁사와의 차별화를 강화하여 지속적인 시장 성장을 지원합니다. 예를 들어, 2024년 6월 미국 제약사 AbbVie는 미국 식품의약국(FDA)이 중등도에서 중증의 활동성 궤양성 대장염 성인 환자를 위한 SKYRIZI(R)(리산키주맙-rzaa)를 승인했다고 발표했습니다. 이로써 SKYRIZI는 중등도에서 중증의 궤양성 대장염과 중등도에서 중증의 크론병 모두에 대해 승인된 최초의 IL-23 특이적 억제제가 되었습니다. 3 스카이리치는 현재 면역 매개 염증성 질환에서 4가지 적응증으로 승인됐습니다.
세계의 스카이리치 시장은 고도로 집중되어 있으며, 주요 기업들이 시장에서 사업을 전개하고 있습니다. 2024년 기준, 주요 기업의 시장 점유율은 전체 시장의 100.0%를 차지했습니다.
자주 묻는 질문
목차
제1장 주요 요약
제2장 목차
제3장 표 리스트
제4장 그래프 리스트
제5장 보고서 구성
제6장 시장 특징
제7장 스카이리치 시장 생물학적 제제 특성
제8장 세계의 스카이리치 가격 분석과 예측
제9장 임상 적응증에 관한 Skyrizi 세계의 역학
제10장 세계의 스카이리치 시장 파이프라인 분석
제11장 주요 시장 동향
제12장 세계의 스카이리치 : 성장 분석 및 전략적 분석 프레임워크
제13장 세계의 스카이리치 : 시장 세분화
제14장 스카이리치 시장 : 지역 및 국가별 분석
제15장 아시아태평양 시장
제16장 서유럽 시장
제17장 동유럽 시장
제18장 북미 시장
제19장 남미 시장
제20장 중동 시장
제21장 아프리카 시장
제22장 경쟁 구도와 기업 개요
제23장 기회와 전략
제24장 스카이리치 시장 : 결론과 제안
제25장 부록
KTH 26.06.02Skyrizi is a prescription biologic medicine containing risankizumab, a humanized monoclonal antibody that selectively inhibits interleukin-23 (IL-23), a key cytokine involved in inflammatory and immune responses. It is administered by injections and is approved for the treatment of immune-mediated inflammatory diseases, most notably moderate to severe plaque psoriasis. The primary purpose of skyrizi is to reduce inflammation and control disease symptoms by targeting a specific immune pathway rather than broadly suppressing the immune system.
The skyrizi market consists of sales by entities (organizations, sole traders and partnerships) of skyrizi that is typically used on a long-term basis, with dosing intervals varying by disease indication and treatment stage. It complements or substitutes other biologic drugs such as adalimumab, ustekinumab, and infliximab, as well as non-biologic systemic treatments like corticosteroids and immunosuppressants.
The global skyrizi market was valued at $1,590.0 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 54.00%.
Rise In Patient Access Programs
During the historic period, the skyrizi market was significantly driven by the rise in patient access programs. As healthcare systems increasingly adopted digital health infrastructure and patient-centric access frameworks, a growing proportion of individuals became more actively involved in managing chronic conditions, monitoring treatment progress, and participating in long-term care decisions. For instance, in September 2025, according to a HealthIT.gov data brief, U.S. hospitals significantly expanded patient access and engagement capabilities between 2021 and 2024, with the share of hospitals adopting all foundational electronic access functions (view, download, transmit, messaging) rising from 72 % in 2021 to 80 % in 2024. Emerging capabilities such as access to clinical notes and app-based health information use also increased from 65 % to 85 % over the same period. Advanced patient access tools like record import and patient-generated data submission grew from 37 % to 45 %. By 2024, nearly all hospitals enabled patients to view (99 %) and download (96 %) their health records electronically, and 92 % supported secure provider messaging. Therefore, the skyrizi market was significantly driven by the rise in patient access programs during the historic period.
Expanding Regulatory Approvals For IL-23 Inhibitors
Companies in the skyrizi market are focusing on expanding regulatory approvals for IL-23 inhibitors to strengthen skyrizi's position across multiple immune-mediated inflammatory diseases. Broader approvals enable access to larger and more diverse patient populations, including those with limited response to existing biologics. This expansion enhances physician adoption by positioning skyrizi as a versatile, disease-modifying therapy. Additionally, multi-indication approvals support sustained market growth by extending product lifecycle and reinforcing competitive differentiation. For example, in June 2024, AbbVie, a US-based pharmaceutical company, announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI(R) (risankizumab-rzaa) for adults with moderately to severely active ulcerative colitis, making it the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and moderate to severe Crohn's disease.3 SKYRIZI is now approved for four indications across immune-mediated inflammatory diseases.
The global skyrizi market is highly concentrated, with large players operating in the market. The top competitors in the market made up to 100.0% of the total market in 2024.
Skyrizi Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global skyrizi market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for skyrizi? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The skyrizi market global report from The Business Research Company answers all these questions and many more. The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider skyrizi market, and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics: - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by indication, by formulation and by distribution channel.
- Key Trends: - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Growth Analysis And Strategic Analysis Framework: - Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Global Market Size And Growth: - Global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis: Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
- Market Segmentation: Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by indication, by formulation and by distribution channel in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
- Regional Market Size And Growth: Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape: Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Key Mergers And Acquisitions: Information on recent mergers and acquisitions in the market covered in the report.
- Recent Developments: Information on recent developments in the market covered in the report.
- Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations This section includes recommendations for skyrizi in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix: This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- 1) By Indication: Psoriatic Disease; Crohn's Disease; Ulcerative Colitis
- 2) By Formulation: Pre-Filled Syringes; Vials
- 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- Companies Mentioned: AbbVie Inc.
- Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; skyrizi indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1 Executive Summary
- 1.1 Skyrizi - Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
- 6.1 General Market Definition
- 6.2 Summary
- 6.3 Skyrizi Market Definition And Segmentations
- 6.4 Market Segmentation By Indication
- 6.4.1 Psoriatic Disease
- 6.4.2 Crohn's Disease
- 6.4.3 Ulcerative Colitis
- 6.5 Market Segmentation By Formulation
- 6.5.1 Pre-Filled Syringes
- 6.5.2 Vials
- 6.6 Market Segmentation By Distribution Channel
- 6.6.1 Hospital Pharmacies
- 6.6.2 Retail Pharmacies
- 6.6.3 Online Pharmacies
7 Skyrizi Market Biologic Drug Characteristics
- 7.1 Molecule Type
- 7.2 Route Of Administration (ROA)
- 7.3 Mechanism Of Action (MOA)
- 7.4 Safety And Efficacy
- 7.4.1 Efficacy
- 7.4.2 Safety Profile
8 Global Skyrizi Pricing Analysis & Forecasts
- 8.1 Current Global Pricing Landscape
- 8.2 Regional Price Variations
- 8.3 Drivers of Price Dynamics
- 8.4 Short-Term Price Forecast (2025-2028)
- 8.5 Revenue & Market Growth Forecasts
- 8.6 Impact of Biosimilars & Long-Term Outlook
9 Global Skyrizi Epidemiology Of Clinical Indications
- 9.1 Drug Side Effects
- 9.2 Incidence And Prevalence of Clinical Indications
10 Global Skyrizi Market Pipeline Analysis
- 10.1 High Level Clinical Trial Information
11 Major Market Trends
- 11.1 Expansion Of Indication Approvals For Advanced Biologic Therapies
- 11.2 Expanding Regulatory Approvals For IL-23 Inhibitors
12 Global Skyrizi Growth Analysis And Strategic Analysis Framework
- 12.1 Global PESTEL Analysis
- 12.1.1 Political
- 12.1.2 Economic
- 12.1.3 Social
- 12.1.4 Technological
- 12.1.5 Environmental
- 12.1.6 Legal
- 12.2 Analysis Of End Users (B2C Market)
- 12.2.1 Dermatologists
- 12.2.2 Gastroenterologists
- 12.2.3 Specialty Pharmacies
- 12.2.4 Hospital Outpatient Pharmacies
- 12.3 Global Skyrizi Market Growth Rate Analysis
- 12.4 Historic Market Growth, 2020 - 2025, Value ($ Million)
- 12.4.1 Market Drivers 2020 - 2025
- 12.4.2 Market Restraints 2020 - 2025
- 12.5 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
- 12.5.1 Market Drivers 2025 - 2030
- 12.5.2 Market Restraints 2025 - 2030
- 12.6 Total Addressable Market for the Skyrizi Market - Business to Customer (B2C)
- 12.6.1 TAM Comparison Analysis
13 Global Skyrizi Market Segmentation
- 13.1 Global Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.2 Global Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.3 Global Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
14 Skyrizi Market, Regional and Country Analysis
- 14.1 Global Skyrizi Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.2 Global Skyrizi Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
15 Asia-Pacific Market
- 15.1 Summary
- 15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Investments
- 15.2.11 Major Companies
- 15.3 Asia Pacific Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.4 Asia Pacific Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.5 Asia Pacific Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.6 Asia-Pacific Skyrizi Market: Country Analysis
- 15.7 China Market
- 15.8 Summary
- 15.9 Market Overview
- 15.9.1 Country Information
- 15.9.2 Market Information
- 15.9.3 Background Information
- 15.9.4 Government Initiatives
- 15.9.5 Regulations
- 15.9.6 Regulatory Bodies
- 15.9.7 Major Associations
- 15.9.8 Taxes Levied
- 15.9.9 Corporate Tax Structure
- 15.9.10 Investments
- 15.9.11 Major Companies
- 15.10 China Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.11 China Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.12 China Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.13 India Market
- 15.14 India Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.15 India Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.16 India Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.17 Japan Market
- 15.18 Summary
- 15.19 Market Overview
- 15.19.1 Country Information
- 15.19.2 Market Information
- 15.19.3 Background Information
- 15.19.4 Government Initiatives
- 15.19.5 Regulations
- 15.19.6 Regulatory Bodies
- 15.19.7 Major Associations
- 15.19.8 Taxes Levied
- 15.19.9 Corporate Tax Structure
- 15.19.10 Major Companies
- 15.20 Japan Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.21 Japan Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.22 Japan Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.23 Australia Market
- 15.24 Australia Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.25 Australia Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.26 Australia Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.27 Indonesia Market
- 15.28 Indonesia Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.29 Indonesia Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.30 Indonesia Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.31 South Korea Market
- 15.32 Summary
- 15.33 Market Overview
- 15.33.1 Country Information
- 15.33.2 Market Information
- 15.33.3 Background Information
- 15.33.4 Government Initiatives
- 15.33.5 Regulations
- 15.33.6 Regulatory Bodies
- 15.33.7 Major Associations
- 15.33.8 Taxes Levied
- 15.33.9 Corporate Tax Structure
- 15.33.10 Investments
- 15.33.11 Major Companies
- 15.34 South Korea Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.35 South Korea Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.36 South Korea Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
16 Western Europe Market
- 16.1 Summary
- 16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Investments
- 16.2.11 Major Companies
- 16.3 Western Europe Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.4 Western Europe Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.5 Western Europe Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.6 Western Europe Skyrizi Market: Country Analysis
- 16.7 UK Market
- 16.8 UK Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.9 UK Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.10 UK Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.11 Germany Market
- 16.12 Germany Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.13 Germany Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.14 Germany Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.15 France Market
- 16.16 France Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.17 France Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.18 France Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.19 Italy Market
- 16.20 Italy Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.21 Italy Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.22 Italy Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.23 Spain Market
- 16.24 Spain Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.25 Spain Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.26 Spain Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
17 Eastern Europe Market
- 17.1 Summary
- 17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Major Companies
- 17.3 Eastern Europe Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.4 Eastern Europe Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.5 Eastern Europe Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.6 Eastern Europe Skyrizi Market: Country Analysis
- 17.7 Russia Market
- 17.8 Russia Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.9 Russia Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.10 Russia Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
18 North America Market
- 18.1 Summary
- 18.2 Market Overview
- 18.2.1 Region Information
- 18.2.2 Market Information
- 18.2.3 Background Information
- 18.2.4 Government Initiatives
- 18.2.5 Regulations
- 18.2.6 Regulatory Bodies
- 18.2.7 Major Associations
- 18.2.8 Taxes Levied
- 18.2.9 Corporate Tax Structure
- 18.2.10 Investments
- 18.2.11 Major Companies
- 18.3 North America Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.4 North America Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.5 North America Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.6 North America Skyrizi Market: Country Analysis
- 18.7 USA Market
- 18.8 Summary
- 18.9 Market Overview
- 18.9.1 Country Information
- 18.9.2 Market Information
- 18.9.3 Background Information
- 18.9.4 Government Initiatives
- 18.9.5 Regulations
- 18.9.6 Regulatory Bodies
- 18.9.7 Major Associations
- 18.9.8 Taxes Levied
- 18.9.9 Corporate Tax Structure
- 18.9.10 Investments
- 18.9.11 Major Companies
- 18.10 USA Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.11 USA Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.12 USA Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.13 Canada Market
- 18.14 Summary
- 18.15 Market Overview
- 18.15.1 Country Information
- 18.15.2 Market Information
- 18.15.3 Background Information
- 18.15.4 Government Initiatives
- 18.15.5 Regulations
- 18.15.6 Regulatory Bodies
- 18.15.7 Major Associations
- 18.15.8 Taxes Levied
- 18.15.9 Corporate Tax Structure
- 18.15.10 Investments
- 18.15.11 Major Companies
- 18.16 Canada Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.17 Canada Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.18 Canada Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
19 South America Market
- 19.1 Summary
- 19.2 Market Overview
- 19.2.1 Region Information
- 19.2.2 Market Information
- 19.2.3 Background Information
- 19.2.4 Government Initiatives
- 19.2.5 Regulations
- 19.2.6 Regulatory Bodies
- 19.2.7 Major Associations
- 19.2.8 Taxes Levied
- 19.2.9 Corporate Tax Structure
- 19.2.10 Major Companies
- 19.3 South America Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.4 South America Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.5 South America Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.6 South America Skyrizi Market: Country Analysis
- 19.7 Brazil Market
- 19.8 Brazil Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.9 Brazil Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.10 Brazil Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
20 Middle East Market
- 20.1 Summary
- 20.2 Market Overview
- 20.2.1 Region Information
- 20.2.2 Market Information
- 20.2.3 Background Information
- 20.2.4 Government Initiatives
- 20.2.5 Regulations
- 20.2.6 Regulatory Bodies
- 20.2.7 Major Associations
- 20.2.8 Taxes Levied
- 20.2.9 Corporate Tax Structure
- 20.2.10 Major Companies
- 20.3 Middle East Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 20.4 Middle East Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 20.5 Middle East Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
21 Africa Market
- 21.1 Market Overview
- 21.1.1 Region Information
- 21.1.2 Market Information
- 21.1.3 Background Information
- 21.1.4 Government Initiatives
- 21.1.5 Regulations
- 21.1.6 Regulatory Bodies
- 21.1.7 Major Associations
- 21.1.8 Taxes Levied
- 21.1.9 Corporate Tax Structure
- 21.1.10 Major Companies
- 21.2 Africa Skyrizi Market, Segmentation By Indication, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 21.3 Africa Skyrizi Market, Segmentation By Formulation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 21.4 Africa Skyrizi Market, Segmentation By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
22 Competitive Landscape And Company Profiles
- 22.1 Company Profiles
- 22.2 AbbVie Inc.
- 22.2.1 Company Overview
- 22.2.2 Products And Services
- 22.2.3 Business Strategy
- 22.2.4 Financial Overview
23 Opportunities And Strategies
- 23.1 Global Skyrizi Market In 2030 - Countries Offering Most New Opportunities
- 23.2 Global Skyrizi Market In 2030 - Segments Offering Most New Opportunities
- 23.3 Global Skyrizi Market In 2030 - Growth Strategies
- 23.3.1 Market Trend Based Strategies
- 23.3.2 Competitor Strategies
24 Skyrizi Market, Conclusions And Recommendations
- 24.1 Conclusions
- 24.2 Recommendations
- 24.2.1 Product
- 24.2.2 Place
- 24.2.3 Price
- 24.2.4 Promotion
- 24.2.5 People
25 Appendix
- 25.1 Geographies Covered
- 25.2 Market Data Sources
- 25.3 Research Methodology
- 25.4 Currencies
- 25.5 The Business Research Company
- 25.6 Copyright and Disclaimer
